Advertisement
CNVVF vs SERA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNVVF is a Hold and SERA is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CNVVF’s FA Score shows that 1 FA rating(s) are green whileSERA’s FA Score has 0 green FA rating(s).
- CNVVF’s FA Score: 1 green, 4 red.
- SERA’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CNVVF’s TA Score shows that 0 TA indicator(s) are bullish while SERA’s TA Score has 5 bullish TA indicator(s).
- CNVVF’s TA Score: 0 bullish, 3 bearish.
- SERA’s TA Score: 5 bullish, 5 bearish.
Price Growth
CNVVF (@Pharmaceuticals: Other) experienced а -13.43% price change this week, while SERA (@Medical/Nursing Services) price change was -6.36% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.13%. For the same industry, the average monthly price growth was -3.06%, and the average quarterly price growth was +8.48%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.97%. For the same industry, the average monthly price growth was +2.80%, and the average quarterly price growth was +8.73%.
Reported Earning Dates
SERA is expected to report earnings on Nov 05, 2025.
Industries' Descriptions
@Pharmaceuticals: Other (-1.13% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (-1.97% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| CNVVF | SERA | CNVVF / SERA | |
| Capitalization | 5.99B | 118M | 5,072% |
| EBITDA | 567M | -31.85M | -1,780% |
| Gain YTD | 0.346 | -62.039 | -1% |
| P/E Ratio | 27.36 | N/A | - |
| Revenue | 2.36B | 108K | 2,181,481% |
| Total Cash | 95.7M | 40.2M | 238% |
| Total Debt | 1.34B | 351K | 381,766% |
CNVVF | ||
|---|---|---|
OUTLOOK RATING 1..100 | 92 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 21 Undervalued | |
PROFIT vs RISK RATING 1..100 | 77 | |
SMR RATING 1..100 | 86 | |
PRICE GROWTH RATING 1..100 | 64 | |
P/E GROWTH RATING 1..100 | 78 | |
SEASONALITY SCORE 1..100 | 55 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| CNVVF | SERA | |
|---|---|---|
| RSI ODDS (%) | N/A | 3 days ago 87% |
| Stochastic ODDS (%) | N/A | 3 days ago 80% |
| Momentum ODDS (%) | 3 days ago 24% | 3 days ago 90% |
| MACD ODDS (%) | 3 days ago 39% | 3 days ago 90% |
| TrendWeek ODDS (%) | 3 days ago 22% | 3 days ago 89% |
| TrendMonth ODDS (%) | 3 days ago 17% | 3 days ago 80% |
| Advances ODDS (%) | N/A | 25 days ago 82% |
| Declines ODDS (%) | N/A | 6 days ago 89% |
| BollingerBands ODDS (%) | N/A | 3 days ago 79% |
| Aroon ODDS (%) | 3 days ago 18% | 4 days ago 89% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XSW | 199.51 | 1.55 | +0.78% |
| SPDR® S&P Software & Services ETF | |||
| XTJA | 30.75 | 0.09 | +0.31% |
| Innovator US Equity Acclrtd Pls ETF Jan | |||
| GNT | 7.00 | N/A | N/A |
| GAMCO Natural Resources Gold & Income Trust | |||
| PBJN | 29.26 | N/A | N/A |
| PGIM S&P 500 Buffer 20 ETF - Jun | |||
| JMUB | 50.37 | -0.05 | -0.10% |
| JPMorgan Municipal ETF | |||
CNVVF and
Correlation & Price change
A.I.dvisor indicates that over the last year, CNVVF has been loosely correlated with SERA. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if CNVVF jumps, then SERA could also see price increases.
| Ticker / NAME | Correlation To CNVVF | 1D Price Change % | ||
|---|---|---|---|---|
| CNVVF | 100% | N/A | ||
| SERA - CNVVF | 33% Loosely correlated | +4.75% | ||
| TMCI - CNVVF | 27% Poorly correlated | -0.30% | ||
| SAFLY - CNVVF | 26% Poorly correlated | N/A | ||
| NMTC - CNVVF | 22% Poorly correlated | +2.22% | ||
| STVN - CNVVF | 22% Poorly correlated | +2.23% | ||
More | ||||
SERA and
Correlation & Price change
A.I.dvisor indicates that over the last year, SERA has been loosely correlated with VAPO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SERA jumps, then VAPO could also see price increases.
| Ticker / NAME | Correlation To SERA | 1D Price Change % | ||
|---|---|---|---|---|
| SERA | 100% | +4.75% | ||
| VAPO - SERA | 41% Loosely correlated | N/A | ||
| CNVVF - SERA | 33% Loosely correlated | N/A | ||
| UTMD - SERA | 30% Poorly correlated | +0.59% | ||
| AMIX - SERA | 28% Poorly correlated | +1.94% | ||
| HBIO - SERA | 27% Poorly correlated | +1.07% | ||
More | ||||